Jess S. Morgan & Co’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,000	Closed	-$32K	–	39
2022 Q2	$32K	Buy	20,000 +5,000	+33%	+$8K	0.03%	37
2022 Q1	$23K	Hold	15,000	–	–	0.02%	43
2021 Q4	$37K	Hold	15,000	–	–	0.02%	45
2021 Q3	$38K	Buy	+15,000	New	+$38K	0.03%	41